Market Place
Sourcing Support
All News #Library
Others
Polyrizon Intends to Acquire up to 20% Stake in Colugo
24 Mar 2026 //
GLOBENEWSWIRE
Polyrizon Inks Deal with Global CRO for Trials
17 Mar 2026 //
GLOBENEWSWIRE
Polyrizon Seeks Controlling Stake In Profitable Jet Operator
10 Feb 2026 //
GLOBENEWSWIRE
Polyrizon Inks Deal For Intranasal Neuroplastogen Formulation
06 Feb 2026 //
GLOBENEWSWIRE
Polyrizon Intends to Acquire 51% Stake in Global Private Aviation
04 Feb 2026 //
GLOBENEWSWIRE
Polyrizon Achieves Promising Naloxone Results
11 Dec 2025 //
GLOBENEWSWIRE
Polyrizon Maintains Nasdaq Listing After Hearings Panel
15 Jul 2025 //
GLOBENEWSWIRE
Polyrizon Shows Nasal Hydrogel Success for CNS Drugs
12 Jun 2025 //
GLOBENEWSWIRE
Polyrizon Emerges with Data on Nasal Protection Platform
21 May 2025 //
GLOBENEWSWIRE
Polyrizon Targets $3.15B Epilepsy Market with Preclinical Work
13 May 2025 //
GLOBENEWSWIRE
Polyrizon Hires Branding Firm for Brand Development
02 Apr 2025 //
GLOBENEWSWIRE
Polyrizon Plans Clinical Strategy For Allergy Blocker Before FDA
27 Mar 2025 //
GLOBENEWSWIRE
Polyrizon Starts Preclinical Studies for Intranasal Naloxone
13 Mar 2025 //
GLOBENEWSWIRE
Polyrizon Files Divisional Patent For Trap & Intranasal Platform
30 Jan 2025 //
GLOBENEWSWIRE
Polyrizon Prepare GMP Manufacturing For PL-14 Allergy Blocker Trial
23 Jan 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.